VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Germline von Hippel-Lindau tumour suppressor gene (VHL) mutations cause renal cell carcinomas, haemangioblastomas and phaeochromocytomas in humans. Mutations in VHL also occur in sporadic renal cell carcinomas. The protein encoded by VHL, VHL, is part of the ubiquitin ligase that downregulates the heterodimeric transcription factor Hif under well-oxygenated conditions. Here we show that acute VHL inactivation causes a senescent-like phenotype in vitro and in vivo. This phenotype was independent of p53 and Hif but dependent on the retinoblastoma protein (Rb) and the SWI2/SNF2 chromatin remodeller p400. Rb activation occurred through a decrease in Skp2 messenger RNA, which resulted in the upregulation of p27 in a Hif-independent fashion. Our results suggest that senescence induced by VHL inactivation is a tumour-suppressive mechanism that must be overcome to develop VHL-associated neoplasias.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One recent example supports this model: loss of function of the Von Hippel Lindau (VHL) tumour suppressor creates an oncogenic stress that triggers a senescence response both in vitro and in vivo.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [128]
In the citing paper
“This senescent cell cycle arrest depends on the presence of functional RB128 and is in part mediated by the RB–SKP2 (S-phase kinase-associated protein 2)–p27 pathway.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [128]
In the citing paper
“This senescent cell cycle arrest depends on the presence of functional RB128 and is in part mediated by the RB–SKP2 (S-phase kinase-associated protein 2)–p27 pathway.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [128]
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., & Livingston, D. M. (1988) · Cell · doi:10.1016/0092-8674(88)90559-4 · Cited by 1,459
Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., & Harlow, E. (1988) · Nature · doi:10.1038/334124a0 · Cited by 1,403
Hayashi, S., & McMahon, A. P. (2002) · Developmental Biology · doi:10.1006/dbio.2002.0597 · Cited by 1,342
Lowe, S. W., Cepero, E., & Evan, G. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,309
Di Leonardo, A., Linke, S. P., Clarkin, K., & Wahl, G. M. (1994) · Genes & Development · doi:10.1101/gad.8.21.2540 · Cited by 1,215
Research works printed but not linked: 1
- Hayashi, S. & McMahon, A. P. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev. Biol. 244, 305–318 (2002). · DOI · Paper page
Cited by
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Cellular Senescence: Aging, Cancer, and Injury
Calcinotto, A., Kohli, J., Zagato, E., Pellegrini, L., Demaria, M., & Alimonti, A. (2019) · Physiological Reviews · doi:10.1152/physrev.00020.2018 · Cited by 1,270
“Studies in murine models clarified that von Hippel–Lindau inactivation induced cellular senescence and benign renal tumors through the upregulation of pRB and p27 in a process dependent on functional p53 and HIF (361).”
BackgroundSystematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
Dalgliesh, G. L., Furge, K., Greenman, C., Chen, L., Bignell, G., Butler, A., Davies, H., Edkins, S., Hardy, C., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08672 · Cited by 1,173
Senescence in tumours: evidence from mice and humans
Collado, M., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2772 · Cited by 1,124
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
Varela, I., Tarpey, P., Raine, K., Huang, D., Ong, C. K., Stephens, P., Davies, H., Jones, D., Lin, M.-L., Teague, J., et al. (2011) · Nature · doi:10.1038/nature09639 · Cited by 1,123
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974
VHL, the story of a tumour suppressor gene
Gossage, L., Eisen, T., & Maher, E. R. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3844 · Cited by 774
Chan, S. Y., Zhang, Y.-Y., Hemann, C., Mahoney, C. E., Zweier, J. L., & Loscalzo, J. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.015 · Cited by 702
“In comparison to tamoxifen-treated VHL flox/flox littermate control mice (referred to as ‘‘WT’’), VHL / mice demonstrate significantly higher levels of miR210 in kidney, liver, and heart (Figure 2C), corresponding with elevated HIF-1a expression (Young et al., 2008).”
Role of hypoxia in the hallmarks of human cancer
Ruan, K., Song, G., & Ouyang, G. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22214 · Cited by 489
Pro-senescence therapy for cancer treatment
Nardella, C., Clohessy, J. G., Alimonti, A., & Pandolfi, P. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3057 · Cited by 437
Genetic Interactions in Cancer Progression and Treatment
Ashworth, A., Lord, C. J., & Reis-Filho, J. S. (2011) · Cell · doi:10.1016/j.cell.2011.03.020 · Cited by 426
Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence
Lin, H.-K., Chen, Z., Wang, G., Nardella, C., Lee, S.-W., Chan, C.-H., Yang, W.-L., Wang, J., Egia, A., Nakayama, K. I., et al. (2010) · Nature · doi:10.1038/nature08815 · Cited by 400
The VHL/HIF axis in clear cell renal carcinoma
Shen, C., & Kaelin, W. G. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.06.001 · Cited by 388
Self-citationCellular senescence in renal ageing and disease
Sturmlechner, I., Durik, M., Sieben, C. J., Baker, D. J., & van Deursen, J. M. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.183 · Cited by 345
Genetic analysis of von Hippel-Lindau disease
Nordstrom-O'Brien, M., van der Luijt, R. B., van Rooijen, E., van den Ouweland, A. M., Majoor-Krakauer, D. F., Lolkema, M. P., van Brussel, A., Voest, E. E., & Giles, R. H. (2010) · Human Mutation · doi:10.1002/humu.21219 · Cited by 311
Hoefflin, R., Harlander, S., Schäfer, S., Metzger, P., Kuo, F., Schönenberger, D., Adlesic, M., Peighambari, A., Seidel, P., Chen, C.-Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17873-3 · Cited by 292
Fumarate induces redox-dependent senescence by modifying glutathione metabolism
Zheng, L., Cardaci, S., Jerby, L., MacKenzie, E. D., Sciacovelli, M., Johnson, T. I., Gaude, E., King, A., Leach, J. D. G., Edrada-Ebel, R., et al. (2015) · Nature Communications · doi:10.1038/ncomms7001 · Cited by 281
Stable expression of HIF-1α in tubular epithelial cells promotes interstitial fibrosis
Kimura, K., Iwano, M., Higgins, D. F., Yamaguchi, Y., Nakatani, K., Harada, K., Kubo, A., Akai, Y., Rankin, E. B., Neilson, E. G., et al. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90209.2008 · Cited by 260
Oncogene-induced senescence: the bright and dark side of the response
Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.07.013 · Cited by 257
Protein damage, repair and proteolysis
Chondrogianni, N., Petropoulos, I., Grimm, S., Georgila, K., Catalgol, B., Friguet, B., Grune, T., & Gonos, E. S. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.09.001 · Cited by 256
Senescence: a new weapon for cancer therapy
Acosta, J. C., & Gil, J. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.11.006 · Cited by 223
A Clearer View of the Molecular Complexity of Clear Cell Renal Cell Carcinoma
Frew, I. J., & Moch, H. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040306 · Cited by 220
pVHL suppresses kinase activity of Akt in a proline-hydroxylation–dependent manner
Guo, J., Chakraborty, A. A., Liu, P., Gan, W., Zheng, X., Inuzuka, H., Wang, B., Zhang, J., Zhang, L., Yuan, M., et al. (2016) · Science · doi:10.1126/science.aad5755 · Cited by 207
Self-citationEmerling, B. M., Hurov, J. B., Poulogiannis, G., Tsukazawa, K. S., Choo-Wing, R., Wulf, G. M., Bell, E. L., Shim, H.-S., Lamia, K. A., Rameh, L. E., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.057 · Cited by 195
“Most strikingly though is the strong increase in p27 (a marker of senescence) (Young and Kaelin, 2008; Young et al., 2008) in the PI5P4K a/b knockdown xenograft tumors compared to the BT474 vector control xenograft tumors (Figure 3K).”
BackgroundSelf-citationVon Hippel-Lindau Disease: Genetics and Role of Genetic Counseling in a Multiple Neoplasia Syndrome
Nielsen, S. M., Rhodes, L., Blanco, I., Chung, W. K., Eng, C., Maher, E. R., Richard, S., & Giles, R. H. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.6140 · Cited by 186
Majumder, P. K., Grisanzio, C., O'Connell, F., Barry, M., Brito, J. M., Xu, Q., Guney, I., Berger, R., Herman, P., Bikoff, R., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.002 · Cited by 178
Self-citationOncogene- and tumor suppressor gene-mediated suppression of cellular senescence
Larsson, L. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.10.005 · Cited by 173
Zeng, J., Ge, Z., Wang, L., Li, Q., Wang, N., Björkholm, M., Jia, J., & Xu, D. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.10.004 · Cited by 172
Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis
Wang, S.-S., Gu, Y.-F., Wolff, N., Stefanius, K., Christie, A., Dey, A., Hammer, R. E., Xie, X.-J., Rakheja, D., Pedrosa, I., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414789111 · Cited by 147
SQSTM1 Is a Pathogenic Target of 5q Copy Number Gains in Kidney Cancer
Li, L., Shen, C., Nakamura, E., Ando, K., Signoretti, S., Beroukhim, R., Cowley, G. S., Lizotte, P., Liberzon, E., Bair, S., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.10.025 · Cited by 161
Self-citationCombined mutation of Vhl and Trp53 causes renal cysts and tumours in mice
Albers, J., Rajski, M., Schönenberger, D., Harlander, S., Schraml, P., von Teichman, A., Georgiev, S., Wild, P. J., Moch, H., Krek, W., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202231 · Cited by 147
Xue, X., Taylor, M., Anderson, E., Hao, C., Qu, A., Greenson, J. K., Zimmermann, E. M., Gonzalez, F. J., & Shah, Y. M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3836 · Cited by 148
Sedic, M., Skibinski, A., Brown, N., Gallardo, M., Mulligan, P., Martinez, P., Keller, P. J., Glover, E., Richardson, A. L., Cowan, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms8505 · Cited by 137
The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease
Seeger‐Nukpezah, T., Geynisman, D. M., Nikonova, A. S., Benzing, T. R., & Golemis, E. A. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.46 · Cited by 148
MC1R Is a Potent Regulator of PTEN after UV Exposure in Melanocytes
Cao, J., Wan, L., Hacker, E., Dai, X., Lenna, S., Jimenez-Cervantes, C., Wang, Y., Leslie, N. R., Xu, G. X., Widlund, H. R., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.010 · Cited by 144
Shamma, A., Takegami, Y., Miki, T., Kitajima, S., Noda, M., Obara, T., Okamoto, T., & Takahashi, C. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.001 · Cited by 140
“For example, PTEN loss-induced prostate carcinogenesis is antagonized by p53- mediated senescence (Chen et al., 2005), and VHL loss-induced cellular senescence is mediated by pRB and p400 (Young et al., 2008).”
BackgroundCellular senescence: hot or what?
Evan, G. I., & di Fagagna, F. D. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.11.009 · Cited by 140
How the Rb tumor suppressor structure and function was revealed by the study of Adenovirus and SV40
DeCaprio, J. A. (2009) · Virology · doi:10.1016/j.virol.2008.12.010 · Cited by 137
Kumar, M., Seeger, W., & Voswinckel, R. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0382ps · Cited by 127
The Paradoxical Role of Cellular Senescence in Cancer
Yang, J., Liu, M., Hong, D., Zeng, M., & Zhang, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.722205 · Cited by 114
Liang Cheng, C., Zhang, S., MacLennan, G. T., Antonio Lopez-beltran, B., & Montironi, R. (2008) · Human Pathology · doi:10.1016/j.humpath.2008.09.009 · Cited by 135
Interplay Between pVHL and mTORC1 Pathways in Clear-Cell Renal Cell Carcinoma
Kucejová, B., Peña‐Llopis, S., Yamasaki, T., Sivanand, S., Tran, T. A. T., Alexander, S., Wolff, N. C., Lotan, Y., Xie, X.-J., Kabbani, W., et al. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0302 · Cited by 127
Zeng, J., Wang, L., Li, Q., Li, W., Björkholm, M., Jia, J., & Xu, D. (2009) · The Journal of Pathology · doi:10.1002/path.2530 · Cited by 126
Piva, F., Santoni, M., Matrana, M. R., Satti, S., Giulietti, M., Occhipinti, G., Massari, F., Cheng, L., López-Beltrán, A., Scarpelli, M., et al. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1068122 · Cited by 125
Shirasaki, R., Matthews, G. M., Gandolfi, S., de Matos Simoes, R., Buckley, D. L., Raja Vora, J., Sievers, Q. L., Brüggenthies, J. B., Dashevsky, O., Poarch, H., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108532 · Cited by 123
MicroRegulators come of age in senescence
Gorospe, M., & Abdelmohsen, K. (2011) · Trends in Genetics · doi:10.1016/j.tig.2011.03.005 · Cited by 108
To clear, or not to clear (senescent cells)? That is the question
Lujambio, A. (2016) · BioEssays · doi:10.1002/bies.201670910 · Cited by 108
Two sides to every story: the HIF-dependent and HIF-independent functions of pVHL
Li, M., & Kim, W. Y. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01238.x · Cited by 109
Hypoxia and Senescence: The Impact of Oxygenation on Tumor Suppression
Welford, S. M., & Giaccia, A. J. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0065 · Cited by 108
Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin
Xu, J., Pham, C. G., Albanese, S. K., Dong, Y., Oyama, T., Lee, C.-H., Rodrik-Outmezguine, V., Yao, Z., Han, S., Chen, D., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86120 · Cited by 97
Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy
Triana-Martínez, F., Loza, M. I., & Domínguez, E. (2020) · Cells · doi:10.3390/cells9020346 · Cited by 95
Regulation of senescence and the SASP by the transcription factor C/EBPβ
Salotti, J., & Johnson, P. F. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110752 · Cited by 103
Noncoding RNA control of cellular senescence
Abdelmohsen, K., & Gorospe, M. (2015) · WIREs RNA · doi:10.1002/wrna.1297 · Cited by 90
pVHL: A Multipurpose Adaptor Protein
Frew, I. J., & Krek, W. (2008) · Science Signaling · doi:10.1126/scisignal.124pe30 · Cited by 95
Early Vascular Ageing and Cellular Senescence in Chronic Kidney Disease
Dai, L., Qureshi, A. R., Witasp, A., Lindholm, B., & Stenvinkel, P. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.06.015 · Cited by 94
Non-Cell-Autonomous Regulation of Cellular Senescence in Cancer
Mitri, D. D., & Alimonti, A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.005 · Cited by 100
Von Hippel-Lindau Disease: Current Challenges and Future Prospects
Gläsker, S., Vergauwen, E., Koch, C. A., Kutikov, A., & Vortmeyer, A. O. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s190753 · Cited by 99
Regulation of KLF4 Turnover Reveals an Unexpected Tissue-Specific Role of pVHL in Tumorigenesis
Gamper, A. M., Qiao, X., Kim, J., Zhang, L., DeSimone, M. C., Rathmell, W. K., & Wan, Y. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.11.031 · Cited by 90
SCFFbw7 Modulates the NFκB Signaling Pathway by Targeting NFκB2 for Ubiquitination and Destruction
Fukushima, H., Matsumoto, A., Inuzuka, H., Zhai, B., Lau, A. W., Wan, L., Gao, D., Shaik, S., Yuan, M., Gygi, S. P., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.04.002 · Cited by 95
Harten, S. K., Shukla, D., Barod, R., Hergovich, A., Balda, M. S., Matter, K., Esteban, M. A., & Maxwell, P. H. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-06-0566 · Cited by 95
Exploiting tumor cell senescence in anticancer therapy
Lee, M., & Lee, J.-S. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.2.005 · Cited by 83
Is DNA damage indispensable for stress-induced senescence?
Bielak-Żmijewska, A., Mosieniak, G., & Sikora, E. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.08.004 · Cited by 92
Hypoxia-Inducible Factor-1α: The Master Regulator of Endothelial Cell Senescence in Vascular Aging
Alique, M., Sánchez-López, E., Bodega, G., Giannarelli, C., Carracedo, J., & Ramírez, R. (2020) · Cells · doi:10.3390/cells9010195 · Cited by 83
Duns, G., Hofstra, R. M. W., Sietzema, J. G., Hollema, H., van Duivenbode, I., Kuik, A., Giezen, C., Osinga, J., de Boer-Bergsma, J. J., Bijnen, H., et al. (2012) · Human Mutation · doi:10.1002/humu.22090 · Cited by 90
Lazorthes, S., Vallot, C., Briois, S., Aguirrebengoa, M., Thuret, J.-Y., Laurent, G. S., Rougeulle, C., Kapranov, P., Mann, C., Trouche, D., et al. (2015) · Nature Communications · doi:10.1038/ncomms6971 · Cited by 78
microRNA-21 Governs TORC1 Activation in Renal Cancer Cell Proliferation and Invasion
Dey, N., Das, F., Ghosh‐Choudhury, N., Mandal, C. C., Parekh, D. J., Block, K. L., Kasinath, B. S., Abboud, H. E., & Choudhury, G. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037366 · Cited by 83
Novel roles of Skp2 E3 ligase in cellular senescence, cancer progression, and metastasis
Wang, G., Chan, C., Gao, Y., & Lin, H. (2011) · 癌症:英文版 · doi:10.5732/cjc.011.10319 · Cited by 83
Caveolin-1, a master regulator of cellular senescence
Volonté, D., & Galbiati, F. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09875-w · Cited by 83
PBRM1, SETD2 and BAP1 — the trinity of 3p in clear cell renal cell carcinoma
Walton, J., Lawson, K. A., Prinos, P., Finelli, A., Arrowsmith, C. H., & Ailles, L. (2022) · Nature Reviews Urology · doi:10.1038/s41585-022-00659-1 · Cited by 82
Hackenbeck, T., Knaup, K. X., Schietke, R. E., Schödel, J., Willam, C., Wu, X., Warnecke, C., Eckardt, K., & Wiesener, M. S. (2009) · Cell Cycle · doi:10.4161/cc.8.9.8306 · Cited by 80
Cdh1 Regulates Cell Cycle through Modulating the Claspin/Chk1 and the Rb/E2F1 Pathways
Gao, D., Inuzuka, H., Korenjak, M., Tseng, A., Wu, T., Wan, L., Kirschner, M. W., Dyson, N. J., & Wei, W. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-01-0092 · Cited by 80
Hypoxic regulation of mRNA expression
Gardner, L. B., & Corn, P. G. (2008) · Cell Cycle · doi:10.4161/cc.7.13.6203 · Cited by 79
Barontini, M., & Dahia, P. L. M. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.01.002 · Cited by 73
Wang, J., Shao, F., Yu, Q., Ye, L., Wusiman, D., Wu, R., Tuo, Z., Wang, Z., Li, D., Cho, W. C. S., et al. (2025) · Research · doi:10.34133/research.0612 · Cited by 72
New Insights into the Biology of Renal Cell Carcinoma
Li, L., & Kaelin, W. G. (2011) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2011.04.004 · Cited by 71
Self-citationEpigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma
Mehdi, A., & Riazalhosseini, Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081774 · Cited by 70
Regulation of Senescence in Cancer and Aging
Kong, Y., Cui, H., Ramkumar, C., & Zhang, H. (2011) · Journal of Aging Research · doi:10.4061/2011/963172 · Cited by 68
Ubiquitin/SUMO Modification Regulates VHL Protein Stability and Nucleocytoplasmic Localization
Cai, Q., & Robertson, E. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012636 · Cited by 65
RetractedBAF180 regulates cellular senescence and hematopoietic stem cell homeostasis through p21
Lee, H., Dai, F., Zhuang, L., Xiao, Z.-D., Kim, J., Zhang, Y., Ma, L., You, M. J., Wang, Z., & Gan, B. (2016) · Oncotarget · doi:10.18632/oncotarget.8102 · Cited by 62
MicroRNAs: exploring a new dimension in the pathogenesis of kidney cancer
White, N. M. A., & Yousef, G. M. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-65 · Cited by 64
The paradox of senescent-marker positive cancer cells: challenges and opportunities
O’Sullivan, E. A., Wallis, R., Mossa, F., & Bishop, C. L. (2024) · npj Aging · doi:10.1038/s41514-024-00168-y · Cited by 62
Nervous system involvement in von Hippel–Lindau disease: pathology and mechanisms
Vortmeyer, A. O., Falke, E., Gläsker, S., Li, J., & Oldfield, E. H. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1091-z · Cited by 62
K63-Ubiquitylation of VHL by SOCS1 mediates DNA double-strand break repair
Metcalf, J. L., Bradshaw, P. S., Komosa, M., Greer, S. N., Meyn, M. S., & Ohh, M. (2013) · Oncogene · doi:10.1038/onc.2013.22 · Cited by 61
Hudes, G. R., Carducci, M. A., Choueiri, T. K., Esper, P., Jonasch, E., Kumar, R., Margolin, K. A., Michaelson, M. D., Motzer, R. J., Пили, Р., et al. (2011) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2011.0124 · Cited by 60
E3 ubiquitin ligase Skp2 as an attractive target in cancer therapy
Hao, Z., & Huang, S. (2015) · Frontiers in bioscience · doi:10.2741/4320 · Cited by 59
Cellular senescence or stemness: hypoxia flips the coin
Otero-Albiol, D., & Carnero, A. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02035-0 · Cited by 58
Js, L., Lee, J.-S., Cui, M. N., Yun, H. H., Kim, H. Y., Lee, S. H., & Lee, J. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.501 · Cited by 57
Cao, X., Xue, L., Han, L., Ma, L., Chen, T., & Tong, T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.225565 · Cited by 57
Epigenetic and Copy Number Variation Analysis in Retinoblastoma by MS-MLPA
Livide, G., Epistolato, M. C., Amenduni, M., Disciglio, V., Marozza, A., Mencarelli, M. A., Toti, P., Lazzi, S., Hadjistilianou, T., Francesco, S. D., et al. (2012) · Pathology & Oncology Research · doi:10.1007/s12253-012-9498-8 · Cited by 56
Lin, T.-Y., Cheng, Y.-C., Yang, H.-C., Lin, W.-C., Wang, C.-C., Lai, P.-L., & Shieh, S.-Y. (2011) · Oncogene · doi:10.1038/onc.2011.491 · Cited by 56
Macías, D., Fernández‐Agüera, M. C., Bonilla, V., & López‐Barneo, J. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404153 · Cited by 55
Wang, J., Liu, L., Qu, Y., Xi, W., Xia, Y., Bai, Q., Xiong, Y., Long, Q., Xu, J., & Guo, J. (2016) · The Journal of Urology · doi:10.1016/j.juro.2016.06.010 · Cited by 55
Clear cell carcinomas of the ovary and kidney: clarity through genomics
Ji, J. X. Y., Wang, Y. K., Cochrane, D. R., & Huntsman, D. D. (2018) · The Journal of Pathology · doi:10.1002/path.5037 · Cited by 55
Molecular and Metabolic Basis of Clear Cell Carcinoma of the Kidney
Akhtar, M., Al‐Bozom, I., & Hussain, T. O. A. (2018) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000185 · Cited by 55
Proliferation of human primary vascular smooth muscle cells depends on serum response factor
Werth, D., Grassi, G., Konjer, N., Dapas, B., Farra, R., Giansante, C., Kandolf, R., Guarnieri, G., Nordheim, A., & Heidenreich, O. T. (2010) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2009.12.002 · Cited by 54
Cancer Response to Therapy-Induced Senescence: A Matter of Dose and Timing
Mongiardi, M. P., Pellegrini, M., Pallini, R., Levi, A., & Falchetti, M. L. (2021) · Cancers · doi:10.3390/cancers13030484 · Cited by 53
Hsu, T. (2011) · Oncogene · doi:10.1038/onc.2011.442 · Cited by 52
Hypoxia and cell cycle regulation of the von Hippel–Lindau tumor suppressor
Liu, W., Xin, H., Eckert, D., Brown, J. A., & Gnarra, J. R. (2010) · Oncogene · doi:10.1038/onc.2010.395 · Cited by 51
Lamin‑B1 is a senescence‑associated biomarker in clear‑cell renal cell carcinoma
Radspieler, M., Schindeldecker, M., Stenzel, P., Foersch, S., Tagscherer, K. E., Herpel, E., Hohenfellner, M., Hatiboglu, G., Roth, W., & Macher‐Goeppinger, S. (2019) · Oncology Letters · doi:10.3892/ol.2019.10593 · Cited by 51
Metadata
- Authors
- Young, A. P., Schlisio, S., Minamishima, Y. A., Zhang, Q., Li, L., Grisanzio, C., Signoretti, S., & Kaelin, W. G.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Kaelin, William G.
- Venue
- Nature Cell Biology
- Published
- 2008-02-24
- Volume
- 10
- Issue
- 3
- Pages
- 361-369
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2158435332
- Cited by
- 239
- References
- 33
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 7 · 2023: 3 · 2022: 4 · 2021: 7 · 2020: 17 · 2019: 13 · 2018: 6 · 2017: 7 · 2016: 18 · 2015: 18 · 2014: 20 · 2013: 19 · 2012: 18
- FWCI
- 15.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- von Hippel-Lindau protein, VHL loss, cellular senescence, retinoblastoma protein, P400, Skp2, p27, tumor suppression, renal cell carcinoma, ubiquitin ligase
- MeSH terms
- Animals, Cells, Cultured, Fibroblasts, Gene Expression Regulation, Membrane Glycoproteins, Mice, Transgenic, Mutation, Oxygen, Phenotype, Retroviridae, Calcium Channels, Retinoblastoma Protein, Cellular Senescence, Receptors, Cytoplasmic and Nuclear, Mice, Hypoxia-Inducible Factor 1, Von Hippel-Lindau Tumor Suppressor Protein, Inositol 1,4,5-Trisphosphate Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.